Status:

UNKNOWN

Slipped Capital Femoral Epiphysis Treatment

Lead Sponsor:

Assiut University

Conditions:

SCFE

Eligibility:

All Genders

10-18 years

Brief Summary

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the medial femoral ci...

Detailed Description

In slipped capital femoral epiphyses (SCFE), the severity of slippage correlates with poor long-term clinical outcome scores and radiographic evidence of osteoarthritis . In situ fixation of higher-gr...

Eligibility Criteria

Inclusion

  • 1- Patients with moderate Slipped capital femoral epiphysis 2- Patients with severe Slipped capital femoral epiphysis

Exclusion

  • Patients with mild Slipped capital femoral epiphysis

Key Trial Info

Start Date :

August 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03229590

Start Date

August 1 2017

End Date

August 1 2020

Last Update

July 25 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Slipped Capital Femoral Epiphysis Treatment | DecenTrialz